General Information of Drug (ID: DMUD7H8)

Drug Name
Unii-I92MU0V408 Drug Info
Synonyms
UNII-I92MU0V408; I92MU0V408; SCHEMBL1695326; CHEMBL3695568; RTDCVLCTBQDLBW-UHFFFAOYSA-N; BDBM142597; RV568; US8933228, Ref 1; RV-568; JNJ-49095397; N-(4-(((4-((((3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)amino)carbonyl)amino)-1-naphthalenyl)oxy)methyl)-2-pyridinyl)-2-methoxyacetamide; Acetamide, N-(4-(((4-((((3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)amino)carbonyl)amino)-1-naphthalenyl)oxy)methyl)-2-pyridinyl)-2-methoxy-; 1220626-82-3; N-[4-({4-[3-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)ur
Cross-matching ID
PubChem CID
45109868
CAS Number
CAS 1220626-82-3
TTD Drug ID
DMUD7H8

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BK3 DM6YQO3 N. A. N. A. Patented [2]
Doramapimod DM6BU7N Inflammatory bowel disease DD72 Patented [1]
3-(6-allyloxy-2-naphthyl)-1-(4-piperidylmethyl)pyrazolo[3,4-d]pyrimidin-4-amine DM0DYAU N. A. N. A. Patented [2]
US8933228, 3 DMPNCOL N. A. N. A. Patented [1]
SB19065 DM2MQD0 N. A. N. A. Patented [3]
US9108950, 1 DMPT2ZS N. A. N. A. Patented [4]
US8933228, Ref 2 DMKEX51 N. A. N. A. Patented [5]
BK7 DMQD4X2 N. A. N. A. Patented [2]
PP121 DMU8KTO Discovery agent N.A. Investigative [6]
PMID15546730C2 DMOPUIH Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hematopoietic cell kinase (HCK) TT42OGM HCK_HUMAN Inhibitor [1]

References

1 Respiratory formulations and compounds for use therein. US8933228.
2 Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases. US9765037.
3 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same. US9062066.
4 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors. US9108950.
5 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors. US9724347.
6 Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9.
7 Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitors. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6061-6.